XOMA Ltd. has made four senior management appointments. Appointments include Robert H. Gundel, Ph.D., vice president, scientific corporate development; Mary Haak-Frendscho, Ph.D., vice president, preclinical R&D; Mark White, vice president, cell and analytical development; and Paul Goodson, senior director, investor relations. In his new role, Dr. Gundel provides corporate leadership to key areas of XOMA’s business, including corporate messaging, business development and specializ...